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Abstract 
Objectives: To report the volume of surgical activity and the number of cancelled surgical 
procedures during the COVID-19 pandemic. 
 
Design and setting: Analysis of electronic health record data from the National Health Service 
(NHS) in England and Wales. 
 
Methods: We used hospital episode statistics for all adult patients undergoing surgery 
between 1st January 2020 and 31st December 2020. We identified surgical procedures using a 
previously published list of procedure codes. Procedures were stratified by urgency of surgery 
as defined by NHS England. We calculated the deficit of surgical activity by comparing the 
expected number of procedures from the years 2016-2019 with the actual number of 
procedures in 2020. We estimated the cumulative number of cancelled procedures by 31st 
December 2021 according patterns of activity in 2020. 
 
Results: The total number of surgical procedures carried out in England and Wales in 2020 
was 3,102,674 compared to the predicted number of 4,671,338. This represents a 33.6% 
reduction in the national volume of surgical activity. There were 763,730  emergency surgical 
procedures (13.4% reduction), compared to 2,338,944 elective surgical procedures (38.6% 
reduction). The cumulative number of cancelled or postponed procedures was 1,568,664. We 
estimate that this will increase to 2,358,420 by 31st December 2021. 
Conclusions: The volume of surgical activity in England and Wales was reduced by 33.6% in 
2020, resulting in over 1,568,664 cancelled operations. This deficit will continue to grow in 
2021. 
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What is already known on this topic:  
• The COVID-19 pandemic necessitated a rapid change in the provision of care, including 
the suspension of a large proportion of surgical activity 
• Surgical activity has yet to return to normal and has been further impacted by 
subsequent waves of the pandemic 
• This will lead to a large backlog of cases  
 
What this study adds:  
• 3,102,674 surgical procedures were performed in England and Wales during 2020, a 
33.6% reduction on the expected yearly surgical activity 
• Over 1.5 million procedures were not performed, with this deficit likely to continue to 
grow to 2.3 million by the end of 2021 
• This deficit is the equivalent of more than 6 months of pre-pandemic surgical activity, 
requiring a monumental financial and logistic challenge to manage 
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Introduction 
The COVID-19 pandemic has fundamentally changed the delivery of healthcare worldwide. In 
many health systems, resources have been reallocated to the care of patients with acute 
SARS-CoV-2 infection and diverted away from routine healthcare services including cancer 
care and chronic disease management.1,2 Critical care capacity was increased, staff and 
equipment were redeployed and, in some cases, new hospitals were built.3-5 In England, the 
National Health Service (NHS) postponed all non-urgent surgery from 15th April 2020 to 
support the response to the first wave of the pandemic, with repetition of these delays from 
December 2020 in response to the second wave.6-8 This has had an enormous, but as yet 
uncharacterised, impact on the provision of surgery, resulting in the cancellation of a large 
portion of elective surgery and delayed urgent surgery for almost an entire year. 
 
In high-income countries, surgical services represent a large portion of healthcare activity.9 In 
the NHS, surgery accounts for over 5 million hospital admissions every year.10,11 However, the 
exact number of surgical procedures that have been cancelled due to COVID-19 is unknown. 
During 2020, there was a phased reintroduction of urgent and elective surgery following the 
first lockdown. However, this was complicated by increased staff sickness, reduced operating 
room capacity and lower throughput due to enhanced infection control policies. In the 
meantime, the waiting list for surgical procedures has continued to grow.12 In a previous 
study, we estimated that over two million surgical procedures would have been cancelled in 
the NHS in England due to the first wave of the pandemic.13 However, this was modelled on 
previous years data and anecdotally observed falls in activity, as well as not accounting for a 
second wave of COVID-19 cases and further associated reductions in surgical activity. 
Therefore, the true impact of COVID-19 on national surgical activity is still unknown. It is 
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crucial that we understand the total number of cancelled surgical procedures, the size of 
waiting list and the priority of these cases, so that healthcare leaders and policy makers are 
able to plan the reintroduction of urgent and elective surgery.  
 
Here, we report the results of a planned analysis of hospital episode data from the NHS in 
England and Wales. We describe the true national volume of surgical activity that occurred 
during the first wave of the COVID-19 pandemic and the initial recovery period, and also 
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Methods 
Study design and setting 
Population-based epidemiological study describing all hospital admissions for a surgical 
procedure in the National Health Service (NHS) in England and Wales between 1st January 
2020 and 31st December 2020. We used data from 1st January 2016 until 31st December 2019 
as a historical comparator period.  
 
Data sources 
We used Hospital Episode Statistics for Admitted Patient Care (HES APC) and Patient Episode 
Data for Wales (PEDW), which describe every episode of hospital care in the NHS in England 
and Wales, respectively. The databases include demographic information (age, sex, ethnicity), 
process information (dates of admission, start of episode, end of episode, reason for 
admission and patient class), and procedural information (recorded using Office of Population 
Censuses and Surveys classification of interventions and procedures version 4.7 [OPCS-4.7] 
codes and associated dates).14,15  
 
Study population 
All patients undergoing surgical procedures in England and Wales in the study period were 
included. Surgical procedures were defined using a previously published definition of surgery 
identified using three-character OPCS-4.7 codes (Appendix A).10,11 
 
Outcomes 
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Duplicate episodes were removed and procedures were restricted to primary procedures 
within each admission episode. This included finished consultant episodes only, which 
excludes hospital episodes where a patient remains in hospital, or where data has not yet 
been submitted to NHS England/NHS Wales. Data were extracted from core data tables in the 
Data Access Environment (England) and the SAIL Databank (Wales). We selected all hospital 
episodes associated with defined OPCS-4.7 codes.10,11. We categorised each procedure 
according to urgency of the surgical procedure using four classes defined by NHS England 
(Appendix B): Emergency (required within 72 hours); Urgent (can be delayed for up to four 
weeks); Semi-urgent (can be delayed for up to three months); Elective (can be delayed for 
more than three months).6 The OPCS 4.7 contributing to these classes were derived from 
average waiting times reported between 2014 to 2019, as previously described.16 We 




Volume of procedures 
Descriptive statistics were used to characterise the volume of procedures performed during 
the historical comparative period (2016-2019) and during 2020. 
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Estimation of the deficit of surgical volume 
The expected monthly frequency of surgical activity from 1st January 2020 to 31st December 
2020 was estimated using the surgical activity during the three-years prior to the study period 
(1st January 2016 to 31st December 2019). A time series model was used to independently 
forecast the total monthly number of procedures and the monthly number of procedures for 
each of the aforementioned surgical classifications. 
 
Modelling analysis 
We calculated the deficit of surgical procedures on 31st December 2020 with a 95% 
confidence interval, based on the difference between the expected and actual number of 
cases that took place in the year to 31st December 2020. We used a linear regression model 
to determine the rate of surgical recovery between the first two waves of the pandemic (April 
to October 2020). We assumed that surgical services would remain disrupted until the end of 
March 2021 and extrapolated growth from that baseline using the linear model to determine 
when surgery would reach normal capacity.  All data were extracted using SQL and analysed 
using IBM SPSS Statistics for Windows (IBM Corp. Released 2017. Version 25.0. Armonk, NY: 
IBM Corp). Graphs were made using ggplot2 package in R (R version 4.0.1, R Core Team, core 
team; Vienna).  
 
Research ethics approval 
This analysis of routinely collected, pseudonymised data was approved by the Health 
Research Authority (20/HRA/3121). Analysis of NHS Wales data was approved by SAIL 
independent Information Governance Review Panel (IGRP) project number 0911. Access to 
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NHS England data was approved by the NHS Digital Independent Group Advising on the 
Release of Data (DARS-NIC-375669-J7M7F). 
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Results 
We identified 3,102,674 admissions for a surgical procedure between 1st January 2020 and 
31st December 2020 (Appendix C). Of these, 2,981,161 (96%) were in England and 121,513 
were in Wales (Appendix D). The median age was 58 (IQR: 38 to 73) years and 54% of the 
cohort were female.  
 
Comparison with the average annual activity 2016-2019 
During the historical period (1st January 2016 to 31st December 2019), there were a median 
of 4,685,106 admissions for surgery per year (IQR 4,4,640,122 – 4,731,338). There were a 
median of 392,720.5 admissions per month (IQR 376,400.3 - 406,084.3). The number of 
procedures expected to have been performed during 2020 was 4,671,338 (95% CI: 4,218,740 
to 5,123,932). During 2020, the lowest number of surgical admissions were observed in the 
month of April with 104,063 (compared to the expected number of 381,153 representing a 
72.7% reduction in surgical activity during this month). The number of admissions during the 
pandemic period, compared to the expected number of admissions is presented in Table 1 
and Figure 1.  
 
Deficit of surgical activity 
The total cumulative deficit of hospital admissions for surgical procedures on the 31st 
December 2020 was 1,568,664 (95%CI: 1,116,066 to 2,021,258) procedures (Figure 1). There 
were 763,730 emergency surgical procedures (13.4% reduction), compared to 2,338,944 
elective surgical procedures (38.6% reduction). The majority of this deficit are represented by 
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semi-urgent surgical procedures in class 3 (904,761 of 1,568,664; 57.7%) and elective surgical 
procedures in class 4 (481,150 of 1,568,664 30.7%) (Table 2).  
 
Number of surgical admissions by urgency of procedure 
In 2020 the majority of surgical activity were class 3 (1,582,808 of 3,102,674, 51.0%). The 
greatest reduction in activity compared to the historical cohort was seen in class 4 procedures 
(448,723 of 929,873 a 51.8% reduction). The number of admissions during 2020, compared 
to the expected number of admissions categorised by class is presented in Table 1 and Figure 
2. 
 
Number of surgical admissions by specialty 
The number of admissions for surgery during 2020, stratified by anatomical surgical site is 
provided in Appendix E. The surgical specialty with the biggest reduction in activity during 
2020 compared to the historical comparator was Oral Surgery (48 %). 
 
Predicted volume of surgical activity in 2021 
If the reintroduction of surgical activity in March 2021 occurs at a similar rate to that observed 
between the first and second waves of the pandemic (April to October 2020), then surgical 
care will reach pre-pandemic activity levels by August 2021 (Figure 3). We estimate a 
cumulative deficit of 2,384,200 (95% CI:  1,667,587 to 3,100,808) surgical procedures between 
1st January 2020 and 31st December 2021 (Table 3). Based on the median monthly number of 
procedures performed during 2016-2019, this is equivalent to more than six months of pre-
pandemic surgical activity. 
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Discussion 
The principle finding of this national observational study is that the overall volume of surgical 
activity in England and Wales during 2020 is 33.6% lower than expected levels. This represents 
the cancellation or postponement of more than 1.5 million surgical procedures. The vast 
majority of the deficit of procedures is accounted for by semi-urgent and elective surgery 
(38.6%). However, there was a substantial reduction in the frequency of emergency surgery 
(13.4%), which has not yet returned to a pre-pandemic baseline. This may be due to a 
reduction in emergency surgical presentations, for example fewer injuries requiring surgery 
due to lockdowns; it may represent an inflation of emergency cases numbers before the 
pandemic (i.e. operations that were not true emergencies) or clinical management using non-
surgical treatment (i.e. conservative or medical therapy). We predict that by the end of 2021 
there will 2.4 million surgical procedures outstanding, representing more than six months of 
normal surgical activity. 
 
Perioperative clinicians in the United Kingdom and worldwide will be familiar with changes to 
working patterns, reductions in operating theatre capacity and increasing waiting lists for 
surgery.5,17 Several research groups have estimated the volume of cancelled surgical 
procedures.8,13,18 However, this is the first study, to our knowledge, to describe the impact of 
the COVID-19 pandemic on the volume of surgical activity at the level of national health 
systems. Our data represent the true reduction in surgical workload that occurred during the 
first wave of the pandemic in England and Wales, and the subsequent (incomplete) recovery 
of surgical services. In the early phase of the pandemic there was a necessary trade off 
between care of a large volume patients with acute respiratory disease, many of whom 
required intensive care treatments, and continuation of services to treat surgical disease. This 
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led to the almost complete cessation of all but the most emergent surgical treatment. The 
reintroduction of surgery after the first wave of the pandemic was complicated by several 
factors. First, concerns about the high-risk of perioperative mortality among surgical patients 
with concomitant SARS-CoV-2 infection and the postponement of surgery on clinical grounds. 
17,19 Second, reduced availability of physical and human resources due to on-going care of 
patients with COVID-19, which limited the capacity of surgical services.20 Third, reduced 
throughput of surgery due to new infection control procedures to prevent nosocomial SARS-
CoV-2 infection and to protect staff members. The consequences of the observed interruption 
to surgical treatment will be felt by millions of patients for many years to come. Delays in the 
diagnosis and the surgical management of cancer will undoubtably lead to an increase in 
cancer related mortality.21 For many patients waiting for semi-urgent and elective surgery, 
there is likely to be a worsening of their condition while waiting for surgery, which could make 
future treatment more difficult and less likely to succeed.22 Furthermore these patients are 
likely to suffer worsening of their physical and mental health while on the waiting list, placing 
additional burdens on primary and social care, reducing their productivity in the workplace.23 
This represents a huge financial and human cost to society.  
 
Dealing with the backlog of surgery will be a challenge to many health systems worldwide.24 
We have previously demonstrated that SARS-CoV-2-free ‘green pathway’ operating is safe, 
with similar perioperative mortality among patients on ‘green pathways’ compared to before 
the pandemic.19 Consequently, surgery should not be delayed or prevented if safeguards are 
put in place. However, this will require significant re-organisation of surgical services and 
financial commitment from central government. Green pathway operating will need 
dedicated space and staff to ensure safety, with routine SARS-CoV-2 testing for patients and 
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staff. With limited personnel and physical resources, it may take many years of concerted 
effort to clear the backlog of surgery due to COVID-19. In the rush to limit harm to surgical 
patients and restart elective surgery as soon as possible, staff welfare should not be 
neglected. A high proportion of healthcare workers have experienced burn out over the last 
year and adequate time for staff recovery should be incorporated into any plan to tackle the 
waiting list for surgery.25 Asking staff that are already tired to work harder for longer may not 
be a sustainable solution to this problem.  
 
This study has several strengths. We included data from all patients undergoing surgery in 
England and Wales during the first wave of the COVID-19 pandemic, thus our results 
represent the true volume of surgery being performed. We include data from 2.5 million 
surgical patients, which represents one of the largest observational cohorts of surgical 
patients during the COVID-19 pandemic. A pre-pandemic cohort of more than 10 million 
patients was used to accurately identify the expected usual surgical activity within the NHS 
for comparison. Official routine data collection is also less open to bias, which can affect other 
data collection methods such as clinician surveys. Furthermore, this data will be generalisable 
to other high-income countries, where similar reductions in surgical activity have been 
reported.26 The pandemic cohort time period was chosen for a number of reasons. While the 
NHS response to COVID-19 began in early March 2020 there is evidence of community 
transmission within the UK prior to this.27 Furthermore, it is important that the winter months 
(January/February/March) were included in this analysis as operating volume is traditionally 
reduced due to other illnesses at this time of year. Our cohort cut off of the 31st December 
2020 allowed us to analyse the first wave and subsequent recovery, leading into the second 
wave of the pandemic, whilst still allowing for data to feed through to national databases and 
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be analysed in a timely manner. This study also has limitations. As with any population-based 
study using routinely collected data there is the risk of incomplete or missing data, although 
from previous work this is likely to be negligible in this setting. Furthermore, the second peak 
of the pandemic did not occur until February 2021 in the UK, so it is likely that surgical activity 
continued to decline after December. We deliberately took a conservative approach in our 
modelling by assuming December was the nadir of surgical activity after April 2020.   
 
Conclusion 
This study is the first to provide operational detail on surgical activity during the COVID-19 
pandemic for an entire health care system. The volume of surgical activity in England and 
Wales in 2020 was 33.6% lower than historical data. Over 1.5 million surgical procedures have 
been cancelled as a result of COVID-19 and we predict that the deficit will rise to 2.4 million 
by the end of 2021. It is imperative that surgical patients are not the forgotten casualties of 
the pandemic. Further work must aim to identify ways to improve utilisation of all available 
capacity for surgical activity, with commitments by governments to make financing this work 
a priority.  
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Table 1 - Observed number of procedures vs expected number of procedures 











expected (95%CI) Observed, N 
Percentage of expected 
(95%CI) 
Jan-20 
      
72,528  99.8 (92.6-108.2)         35,067  106 (95.4-119.2)       216,455  101.5 (91.6-113.7)      75,195  98.0 84.0-117.5) 
Feb-20 
      
67,141  92.4 (85.7-100.1)         31,839  96.2 (86.6-108.2)       201,663  97.7 (87.9-110.0)      72,343  90.3 (77.9-107.3) 
Mar-20 
      
62,355  85.8 (79.6-93.0)         29,629  89.5 (80.5-100.7)       149,742  69.5 (62.8-77.8)      44,496  57.3 (49.7-69.5) 
Apr-20 
      
48,798  67.1 (62.3-72.8)         16,525  49.9 (44.9-56.1)          37,120  18.4 (16.5-20.7)         1,620  2.3 (1.9-2.7) 
May-20 
      
59,597  82.0 (76.1-88.9)         18,012  54.4 (48.9-61.2)          47,274  22.9 (20.6-25.8)         3,542  4.5 (3.8-5.5) 
Jun-20 
      
64,178  88.3 (82.0-95.7)         21,772  65.7 (59.1-73.9)          77,975  38.2 (34.4-43.1)      11,033  14.1 (12.0-17.3) 
Jul-20 
      
70,633  97.2 (90.2-105.3)         24,988  75.4 (67.8-84.8)       113,141  53.2 (48.0-59.6)      23,619  30.3 (25.6-36.9) 
Aug-20 
      
68,898  94.8 (88.0-102.8)         23,183  69.9 (62.9-78.6)       118,748  59.1 (53.0-66.8)      31,785  40.7 (34.3-49.7) 
Sep-20 
      
68,942  94.9 (88.0-102.8)         27,145  81.8 (73.6-92.0)       155,569  74.9 (67.5-84.3)      46,239  59.2 (50.1-72.3) 
Oct-20 
      
67,314  92.6 (86.0-100.4)         27,933  84.1 (75.7-94.7)       168,026  79.4 (71.6-89.1)      53,518  68.6 (58.0-83.7) 
Nov-20 
      
62,125  85.5 (79.3-92.6)         27,007  81.3 (73.2-91.5)       164,060  79.4 (71.4-89.4)      50,154  64.2 (54.4-78.5) 
Dec-20 
      
51,221  70.5 (65.4-76.2)         24,313  73.2 (65.8-82.3)       133,035  67.4 (60.4-76.3)      35,179  45.1 (38.2-55.0) 
Class 1, Emergency surgery with 72 hours; Class 2, Urgent surgery within 4 weeks; Class 3, Semi-urgent surgery within 3 months; Class 4, Elective surgery over 
3 months  
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Table 2 - Monthly and cumulative deficit of number of surgical procedures 





















January 863 863 150 150 0 0 0 0 1,550 1,550 
February 14,055 14,918 5,537 5,687 1,257 1,257 4,773 4,773 7,811 9,361 
March 118,492 133,410 10,323 16,010 3,480 4,737 65,692 70,465 32,291 41,652 
April 277,090 410,500 23,880 39,890 16,597 21,334 165,060 235,525 70,055 111,707 
May 261,176 671,676 13,081 52,971 15,123 36,457 159,167 394,692 74,522 186,229 
June 207,880 879,556 8,500 61,471 11,376 47,833 125,974 520,666 67,031 253,260 
July 167,730 1,047,286 2,045 63,516 8,173 56,006 99,650 620,316 54,445 307,705 
August 137,072 1,184,358 3,780 67,296 9,990 65,996 82,126 702,442 46,279 353,984 
September 92,131 1,276,489 3,736 71,032 6,041 72,037 51,997 754,439 31,825 385,809 
October 79,742 1,356,231 5,364 76,396 5,266 77,303 43,510 797,949 24,546 410,355 
November 83,499 1,439,730 10,553 86,949 6,205 83,508 42,533 840,482 27,910 438,265 
December 128,934 1,568,664 21,457 108,406 8,912 92,420 64,279 904,761 42,885 481,150 
 
Class 1, Emergency surgery with 72 hours; Class 2, Urgent surgery within 4 weeks; Class 3, Semi-urgent surgery within 3 months; Class 4, Elective surgery over 
3 months  
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Table 3. Modelled number of procedures, monthly deficit, and cumulative deficit in 2021. Data are counts of procedures with associated 95% confidence interval 




Modelled number of procedures 
Monthly deficit compared to historical 
period 
Cumulative deficit (2021 only) 
January 243,748 (243,748 to 243,748) 156,360 (118,644 to 194,076) 156,360 (118,644 to 194,076) 
February 243,748 (243,748 to 243,748) 143,293 (105,577 to 181,010) 299,653 (224,221 to 375,086) 
March 243,748 (243,748 to 243,748) 160,966 (123,249 to 198,682) 460,619 (347,470 to 573,768) 
April 243,726 (210,656 to 276,797) 137,427 (99,710 to 175,143) 598,046 (447,180 to 748,911) 
May 281,040 (246,677 to 315,402) 108,561 (70,845 to 146,278) 706,607 (518,025 to 895,189) 
June 318,353 (281,817 to 354,890) 64,485 (26,769 to 102,201) 771,092 (544,794 to 997,390) 
July 355,667 (316,220 to 395,114) 44,444 (6,727 to 82,160) 815,536 (551,521 to 1,079,550) 
August 379,686 (341,969 to 417,402) 0 (0 to 0) 815,536 (551,521 to 1,079,550) 
September 390,026 (352,309 to 427,742) 0 (0 to 0) 815,536 (551,521 to 1,079,550) 
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October 396,533 (358,817 to 434,249) 0 (0 to 0) 815,536 (551,521 to 1,079,550)) 
November 386,845 (349,129 to 424,561) 0 (0 to 0) 815,536 (551,521 to 1,079,550) 
December 372,682 (334,965 to 410,398) 0 (0 to 0) 815,536 (551,521 to 1,079,550) 
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Figure 1 – Top panel: Surgical activity during 2020 (red line) compared to expected surgical activity (blue 
line) based on the years 2016-2019 (with 95% CIs). Bottom panel: Cumulative deficit of surgical 
procedures throughout 2020 (95% CIs).  
 
Figure 2 – Surgical activity by class for 2020 (dotted line) compared to expected surgical activity and 95% 
CI (solid line and shading).  
 
Figure 3 – Predicted surgical activity for 2021 and return to pre-pandemic operative volume. 
 
 
Appendix A – Previous published definition of surgery using three-character Office of Population 
Censuses and Surveys classification of interventions and procedures version 4.7 (OPCS-4.7) codes. 
 
Appendix B – Four class definition of the urgency of surgery as published by NHS England. 
 
Appendix C – Flow diagram demonstrating number of patients identified in study cohort. 
 
Appendix D - Surgical activity in 2020 classified by category of surgery for England and Wales.  
 
Appendix D – Surgical activity in 2020 classified by anatomical site.  
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